Cargando…
Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
Drug screening—i.e., testing the effects of a number of drugs in multiple cell lines—is used for drug discovery and development, and can also be performed to evaluate the heterogeneity of a disease entity. Notably, intertumoral heterogeneity is a large hurdle to overcome for establishing standard ca...
Autores principales: | Kondo, Jumpei, Inoue, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562517/ https://www.ncbi.nlm.nih.gov/pubmed/31108870 http://dx.doi.org/10.3390/cells8050470 |
Ejemplares similares
-
Application of Patient-Derived Cancer Organoids to Personalized Medicine
por: Shiihara, Masahiro, et al.
Publicado: (2022) -
Tracking the growth fate of single cells and isolating slow-growing cells in human colorectal cancer organoids
por: Coppo, Roberto, et al.
Publicado: (2023) -
Development of glioblastoma organoids and their applications in personalized therapy
por: Xu, Can, et al.
Publicado: (2023) -
Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening
por: Yuan, Bo, et al.
Publicado: (2022) -
Small subset of Wnt‐activated cells is an initiator of regrowth in colorectal cancer organoids after irradiation
por: Endo, Hiroko, et al.
Publicado: (2020)